(2S,3S)-4-[6-(6-chloro-7-fluoroimidazo[1,2-a]pyridin-3-yl)pyrazin-2-yl]-2-(3-chlorophenyl)-3-methylmorpholine
C22H18Cl2FN5O — CID 139365260
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,3S)-4-[6-(6-chloro-7-fluoroimidazo[1,2-a]pyridin-3-yl)pyrazin-2-yl]-2-(3-chlorophenyl)-3-methylmorpholine
(2S,3S)-4-[6-(6-chloro-7-fluoroimidazo[1,2-a]pyridin-3-yl)pyrazin-2-yl]-2-(3-chlorophenyl)-3-methylmorpholine (PubChem CID 139365260) has the molecular formula C22H18Cl2FN5O and a molecular weight of 458.32 g/mol. Its IUPAC name is (2S,3S)-4-[6-(6-chloro-7-fluoroimidazo[1,2-a]pyridin-3-yl)pyrazin-2-yl]-2-(3-chlorophenyl)-3-methylmorpholine.
Molecular Properties
| Compound Name | (2S,3S)-4-[6-(6-chloro-7-fluoroimidazo[1,2-a]pyridin-3-yl)pyrazin-2-yl]-2-(3-chlorophenyl)-3-methylmorpholine |
|---|---|
| PubChem CID | 139365260 |
| Molecular Formula | C22H18Cl2FN5O |
| Molecular Weight | 458.32 g/mol |
| Exact Mass | 457.09 |
| IUPAC Name | (2S,3S)-4-[6-(6-chloro-7-fluoroimidazo[1,2-a]pyridin-3-yl)pyrazin-2-yl]-2-(3-chlorophenyl)-3-methylmorpholine |
| SMILES | C[C@H]1[C@H](c2cccc(Cl)c2)OCCN1c1cncc(-c2cnc3cc(F)c(Cl)cn23)n1 |
| InChI | InChI=1S/C22H18Cl2FN5O/c1-13-22(14-3-2-4-15(23)7-14)31-6-5-29(13)21-11-26-9-18(28-21)19-10-27-20-8-17(25)16(24)12-30(19)20/h2-4,7-13,22H,5-6H2,1H3/t13-,22+/m0/s1 |
| InChIKey | PBHXAPHJHGZSDV-WHEQGISXSA-N |
| XLogP | 5.20 |
| TPSA | 55.55 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 458.32 |
| LogP ≤ 5 | 5.20 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139365260 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.